Paclitaxel and N-Methylformamide: In vitro interactions in human colon cancer cell line

Anticancer Research

Volumn 17, Issue 4 A, 1997, Pages 2491-2497

  Valenti, Anna Maria ^a   Niero, Alessandra ^a   Monti, Giuseppe ^a   Marangolo, Federica ^b   Marangolo, Maurizio ^a  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^b S Maria Delle Croci Hospital ^*

Author keywords

Cell cycle kinetics; Clonogenic assay; Colon adenocarcinoma cell line; Cytofluorimetry; Drug combination; N methylformamide; Paclitaxel

Indexed keywords

N METHYLFORMAMIDE; PACLITAXEL;

ARTICLE; CELL CYCLE; CELL KILLING; CELL KINETICS; CELL STRAIN HT29; CELL SURVIVAL; CLINICAL PROTOCOL; CLONOGENIC ASSAY; COLON CANCER; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MITOSIS INHIBITION; PRIORITY JOURNAL;

ADENOCARCINOMA; CELL CYCLE; CELL SURVIVAL; COLONIC NEOPLASMS; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLOW CYTOMETRY; FORMAMIDES; HUMANS; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0030809343     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bloch A: Induced cell differentiation in cancer therapy. Cancer Treat Rep 68: 199-205, 1984.
2. Freshney RI: Induction of differentiation in neoplastic cells. Anticancer Res 5: 111-116, 1985.
3. Collins SJ, Ruscetti FW, and Gallagher RE: Terminal differentiation of human promyelocitic leukemia cells by Dimethil sulfoxide and other polar compounds. Proc Natl Acad Sci USA: 75: 2458-2462, 1978.
4. Tanaka M, Levy J, Terada M, Breslow R, Rifkind RA and Narks PA: Induction of erythroid differentiation in murine virus infected erythroleukemia cells by higiy polar compounds. Proc Natl Acad Sci USA 72: 1003-1006, 1975.
5. Leith JT, Vayer ES, Dexter AJ and Glicksman AS: Enhancement of the responses of human colon adenocarcinoma cells to x-irradiation and cis-platinum by N-Methylformamide (NMF). Int J Radit Oncol Biol Phys 77: 1971-1976, 1985.
6. Leith JT, Lee ES, Leite DV, and Glicksman AS: Enhanced X-ray sensitivity of human colon tumor cells by combination of N-Methylformamide (NMF). Int J Radiat Oncol Biol Phys 12: 1423-1427, 1986.
7. Tofilon PJ, Vines CM, and Milas L: N-Methylformamide mediated enhancement of in vitro tumor cell chemosensitivity. Cancer Chemother Pharmacol 17: 269-273, 1986.
8. Lotan R, Nicolson GL: Can anticancer therapy be improved by sequential use of cytotoxic and cytostatic (differentiating or immunomodulating) agents to suppress tumor cells phenotipic diversification. Biochem Pharmacol 37: 149-154, 1988.
9. Zupi G, Marangolo M, Arancia G, et al: Modulation of the cytotoxic effect of 5-fluorouracil by N-Methylformamide on a Human Colon Carcinoma Cell Line. Cancer Res 48: 6193-6200, 1988.
10. Cucco C, D'Agnano I, Marangolo M, Candiloro A and Zupi G: Importance of cell cycle perturahntions the effectivness of N-Methyilformamide and anti-neoplastic drugs in combination. Cell Prolif 24: 293-303, 1991.
11. Iwakawa M, Tofilon PJ, Arundel C, Milas L: Combination of N-Methylformamide with cis-Diaminodichloroplatinum in murine mammary carcinoma:importance of timing. Cancer Res 49: 1640 1989.
12. Scotlandi K, Serra M, Manara MC, et al: Pre-treatment of human osteosarcoma cells with N-Methylformamide enhances P-glycoprotein expression and resistance to doxorubicin. Int J Cancer 58: 95-101, 1994.
13. Liebmann JE, Cook JA, Lipschultz C, Teague D, Fisher J, and Mitchell J B: Cytotoxic studies of Paclitaxel (Taxol)in human tumor cell lines. Br J Cancer 68: 1104-1109, 1993.
14. Rowinsky EK, Cazenave CA, Doneover RC: Taxol: a novel investigational antimicrotubule agent. J Natl Cancer Inst 82: 1247-1259, 1990.
15. Schiff PB, Fant J, Horowitz SB: Promotion of microtubule assembly in vitro by Taxol. Nature 277: 665-667, 1979.
16. Schiff PB, Horwitz SB: Taxol stabilizes microtubules in mouse fibroblast cells. Proc Natl Acad Sci USA 77: 1561-1565, 1980.
17. Edelman GM: Surface modulation in cell recognition and cell growth. Science 792: 218-226, 1976.
18. Tomisek AJ, Allan PW, Short WA: The effects of methan and N-Methylformamide on pyrimidine metabolism. Cancer Res 29: 93-97, 1969.
19. Marks PA and Rifkind RA: Differentiation modiiiers. Cancer 54: 2766-2769, 1984.
20. Tapiero H, Fourcade A and Billard C: Membrane dynamics of Friend Leukemic cells. II. Changes associated with ceil differentiation. Cell Differ 9: 211-218, 1980.
21. Dibner MD, Ireland KA, Koerner LA and Dexter DL: Polar solventinduced changes in membrane lipid lateral diffusion in human colon cancer cells. Cancer Res: 45: 4998-5003, 1985.
22. Arancia G, Molinari A, Calcabrini A, et al: Effects of sequential combinations of Nmethylformamide with Adriamycin on cultured melanoma cells (M14). Exp Mol Pathol: 60 (1): 12-26, 1994.
23. Malorni W, Meschini S, Arancia G: Cytoskeleton-dependent surface blebbing induced by the polar solvent N-methylformamide. Exp Mol Pathol 57: 85-104, 1992.
24. Cordeiro RF and Savarese TM: Role of glutathione depletion in the mechanism of action of N-methylformamide and N,N-dimethylformamide in a cultured human colon carcinoma cell line. Cancer Res 46: 1297-1305, 1986.